# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-25-012307
Filing Date
2025-04-04
Accepted
2025-04-04 16:06:26
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | ny20041152x2_defa14a.htm | DEFA14A | 19282
2 |  | ny20041152x2_nc01.jpg | GRAPHIC | 406193
3 |  | ny20041152x2_nc02.jpg | GRAPHIC | 295001
| Complete submission text file | 0001140361-25-012307.txt |  | 986541

Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

EIN.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34949 | Film No.: 25814008
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)